INFINITE GROUP INC

2023 Q4 Form 10-Q Financial Statement

#000165495423012978 Filed on October 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q4 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $1.590K
YoY Change 1157.86% -59.95%
Cash & Equivalents $17.34K $1.594K
Short-Term Investments
Other Short-Term Assets $460.0K $198.2K
YoY Change 132.07% 9.31%
Inventory
Prepaid Expenses
Receivables $212.9K $650.4K
Other Receivables $0.00 $0.00
Total Short-Term Assets $692.5K $850.2K
YoY Change -18.55% -13.42%
LONG-TERM ASSETS
Property, Plant & Equipment $11.64K $30.98K
YoY Change -62.43% -34.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.00K $10.14K
YoY Change -1.38% 46.11%
Total Long-Term Assets $1.047M $1.147M
YoY Change -8.71% 113.51%
TOTAL ASSETS
Total Short-Term Assets $692.5K $850.2K
Total Long-Term Assets $1.047M $1.147M
Total Assets $1.740M $1.997M
YoY Change -12.9% 31.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.606M $1.087M
YoY Change 47.81% 203.46%
Accrued Expenses $2.330M $1.521M
YoY Change 53.24% 8.18%
Deferred Revenue
YoY Change
Short-Term Debt $1.690M $1.173M
YoY Change 44.13% 489.21%
Long-Term Debt Due $1.210M $765.0K
YoY Change 58.17% -5.29%
Total Short-Term Liabilities $7.281M $5.315M
YoY Change 36.99% 58.03%
LONG-TERM LIABILITIES
Long-Term Debt $920.0K $1.458M
YoY Change -36.88% -7.64%
Other Long-Term Liabilities $530.0K $612.1K
YoY Change -13.42% 786.77%
Total Long-Term Liabilities $1.450M $2.070M
YoY Change -29.94% 25.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.281M $5.315M
Total Long-Term Liabilities $1.450M $2.070M
Total Liabilities $8.728M $7.385M
YoY Change 18.19% 47.39%
SHAREHOLDERS EQUITY
Retained Earnings -$39.31M -$37.17M
YoY Change 5.77% 7.84%
Common Stock $507.00 $33.56K
YoY Change -98.49% 13.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.989M -$5.388M
YoY Change
Total Liabilities & Shareholders Equity $1.740M $1.997M
YoY Change -12.9% 31.46%

Cashflow Statement

Concept 2023 Q4 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
319350 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
505770 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
506608 shares
dei Entity Central Index Key
EntityCentralIndexKey
0000884650
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
506608 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
470093 shares
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
26159 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Entity File Number
EntityFileNumber
000-21816
dei Entity Registrant Name
EntityRegistrantName
INFINITE GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1490422
dei Entity Address Address Line1
EntityAddressAddressLine1
175 Sully’s Trail
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 202
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsford
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14534
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
385-0610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
521175 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17339 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23187 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32692 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
36710 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
212890 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
406005 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
462260 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
144218 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
692489 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
573410 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604366 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
645095 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11640 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19996 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
420897 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
417325 usd
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
10144 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
10144 usd
CY2023Q2 us-gaap Assets
Assets
1739536 usd
CY2022Q4 us-gaap Assets
Assets
1665970 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1605944 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1687579 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
420602 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
386289 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1301144 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
783581 usd
CY2023Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
292366 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
286605 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
451738 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
550523 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
230336 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
138639 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
549000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
515000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
80762 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
76826 usd
CY2023Q2 igi Current Maturities Of Long Term Obligations Related Parties
CurrentMaturitiesOfLongTermObligationsRelatedParties
659300 usd
CY2022Q4 igi Current Maturities Of Long Term Obligations Related Parties
CurrentMaturitiesOfLongTermObligationsRelatedParties
385000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1491004 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1572857 usd
CY2023Q2 igi Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
199000 usd
CY2022Q4 igi Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
229000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7281196 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6611899 usd
CY2023Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
416473 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
458849 usd
CY2023Q2 igi Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
499000 usd
CY2022Q4 igi Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
886876 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
531374 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
572560 usd
CY2023Q2 us-gaap Liabilities
Liabilities
8728043 usd
CY2022Q4 us-gaap Liabilities
Liabilities
8530184 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
470093 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
507 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
470 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32324991 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32164334 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39314005 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39029018 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6988507 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6864214 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1739536 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1665970 usd
CY2023Q2 us-gaap Revenues
Revenues
1783476 usd
CY2022Q2 us-gaap Revenues
Revenues
1696492 usd
us-gaap Revenues
Revenues
3547469 usd
us-gaap Revenues
Revenues
3363562 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
998215 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1059639 usd
us-gaap Cost Of Revenue
CostOfRevenue
1964421 usd
us-gaap Cost Of Revenue
CostOfRevenue
2180879 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
785261 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
636853 usd
us-gaap Gross Profit
GrossProfit
1583048 usd
us-gaap Gross Profit
GrossProfit
1182683 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
465177 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
613317 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
996822 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1217300 usd
CY2023Q2 us-gaap Selling Expense
SellingExpense
761365 usd
CY2022Q2 us-gaap Selling Expense
SellingExpense
612957 usd
us-gaap Selling Expense
SellingExpense
1454475 usd
us-gaap Selling Expense
SellingExpense
1260582 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1226542 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1226274 usd
us-gaap Operating Expenses
OperatingExpenses
2451297 usd
us-gaap Operating Expenses
OperatingExpenses
2477882 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-441281 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-589421 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-868249 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1295199 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
71324 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
10 usd
us-gaap Interest Income Other
InterestIncomeOther
71624 usd
us-gaap Interest Income Other
InterestIncomeOther
18 usd
CY2023Q2 igi Interest Expense Related Parties
InterestExpenseRelatedParties
30755 usd
CY2022Q2 igi Interest Expense Related Parties
InterestExpenseRelatedParties
22728 usd
igi Interest Expense Related Parties
InterestExpenseRelatedParties
57700 usd
igi Interest Expense Related Parties
InterestExpenseRelatedParties
46142 usd
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
688133 usd
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
221061 usd
us-gaap Interest Expense Other
InterestExpenseOther
1188491 usd
us-gaap Interest Expense Other
InterestExpenseOther
360111 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
718888 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
243789 usd
us-gaap Interest Expense
InterestExpense
1246191 usd
us-gaap Interest Expense
InterestExpense
406253 usd
CY2023Q2 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
95131 usd
CY2022Q2 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
95131 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
CY2023Q2 igi Erc Tax Refund
ErcTaxRefund
1662698 usd
CY2022Q2 igi Erc Tax Refund
ErcTaxRefund
0 usd
igi Erc Tax Refund
ErcTaxRefund
1662698 usd
igi Erc Tax Refund
ErcTaxRefund
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1110265 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
243779 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
583262 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406235 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
668984 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
us-gaap Net Income Loss
NetIncomeLoss
-284987 usd
us-gaap Net Income Loss
NetIncomeLoss
-1701434 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.87
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.87
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
494960 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
443953 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
483243 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
440004 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
638776 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
443953 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
483243 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
440004 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6864214 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
26159 usd
CY2023Q1 igi Warrants Issued Amount
WarrantsIssuedAmount
107834 usd
CY2023Q1 igi Cashless Exercise Of Warrants Amount
CashlessExerciseOfWarrantsAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-953971 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7684192 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26701 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
668984 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6988507 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4097889 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
923 usd
CY2022Q1 igi Warrants Issued Amount
WarrantsIssuedAmount
148334 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-868234 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4816866 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51708 usd
CY2022Q2 igi Warrants Issued Amount
WarrantsIssuedAmount
210816 usd
CY2022Q2 igi Cashless Exercise Of Warrants Amount
CashlessExerciseOfWarrantsAmount
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5387542 usd
us-gaap Profit Loss
ProfitLoss
-284987 usd
us-gaap Profit Loss
ProfitLoss
-1701434 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26159 usd
us-gaap Share Based Compensation
ShareBasedCompensation
52631 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
124154 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
117686 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
635960 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
255042 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8517 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
igi Recovery Of Bad Debts
RecoveryOfBadDebts
4018 usd
igi Recovery Of Bad Debts
RecoveryOfBadDebts
0 usd
igi Foregiveness Of Debt
ForegivenessOfDebt
95131 usd
igi Foregiveness Of Debt
ForegivenessOfDebt
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-197132 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-76894 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
299859 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-17394 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-81635 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
549665 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-98785 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-22334 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
663654 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12014 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
5761 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
5536 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
796922 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-636906 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2099 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
969 usd
igi Proceeds From Sales Of Erc Claim
ProceedsFromSalesOfErcClaim
-1413294 usd
igi Proceeds From Sales Of Erc Claim
ProceedsFromSalesOfErcClaim
0 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
113790 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
110378 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1297405 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111347 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
257645 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
918900 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
295336 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
53445 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1662698 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 usd
igi Repayments Of Note Payable Related Parties
RepaymentsOfNotePayableRelatedParties
30000 usd
igi Repayments Of Note Payable Related Parties
RepaymentsOfNotePayableRelatedParties
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
369786 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
215040 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2100175 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
650415 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5848 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-97838 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23187 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99432 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17339 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1594 usd
us-gaap Interest Paid Net
InterestPaidNet
248549 usd
us-gaap Interest Paid Net
InterestPaidNet
54826 usd
igi Warrant Issued In Conjunction With Debts
WarrantIssuedInConjunctionWithDebts
107834 usd
igi Warrant Issued In Conjunction With Debts
WarrantIssuedInConjunctionWithDebts
359150 usd
igi Common Stock Issued Via Exercise Of Warrant
CommonStockIssuedViaExerciseOfWarrant
7 usd
igi Common Stock Issued Via Exercise Of Warrant
CommonStockIssuedViaExerciseOfWarrant
11 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2022Q2 igi Amortization Expense
AmortizationExpense
53402 usd
us-gaap Net Income Loss
NetIncomeLoss
-284987 usd
us-gaap Net Income Loss
NetIncomeLoss
-1701434 usd
CY2023Q2 igi Stockholders Deficiency
StockholdersDeficiency
6988507 usd
CY2022Q4 igi Stockholders Deficiency
StockholdersDeficiency
6864214 usd
CY2023Q2 igi Working Capital Deficit
WorkingCapitalDeficit
6600000 usd
CY2023Q2 us-gaap Revenues
Revenues
1783476 usd
CY2022Q2 us-gaap Revenues
Revenues
1696492 usd
us-gaap Revenues
Revenues
3547469 usd
us-gaap Revenues
Revenues
3363562 usd
igi Amortization Expense
AmortizationExpense
106803 usd
CY2023Q2 us-gaap Development Costs
DevelopmentCosts
15000 usd
us-gaap Development Costs
DevelopmentCosts
21700 usd
CY2022Q2 us-gaap Development Costs
DevelopmentCosts
7800 usd
us-gaap Development Costs
DevelopmentCosts
16100 usd
igi Increases In Reserves
IncreasesInReserves
21600 usd
igi Retained Amount Rate
RetainedAmountRate
0.10 pure
igi Prime Plus Rate
PrimePlusRate
0.036 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1185 pure
CY2023Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
2000000 usd
CY2023Q2 igi Sublimit For Accounts Receivable For One Customer
SublimitForAccountsReceivableForOneCustomer
1500000 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
1007817 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
894027 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
586920 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
472702 usd
CY2023Q2 igi Amortization Expense
AmortizationExpense
49389 usd
igi Amortization Expense
AmortizationExpense
110218 usd
CY2023Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
123000 usd
CY2022Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
136000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
307000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
278000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
882000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
90000 usd
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
1330464 usd
CY2023Q2 igi Balance Amount
BalanceAmount
82830 usd
CY2023Q2 igi Aggregate Purchase Price
AggregatePurchasePrice
1662698 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
668984 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
us-gaap Net Income Loss
NetIncomeLoss
-284987 usd
us-gaap Net Income Loss
NetIncomeLoss
-1701434 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.87
CY2023Q2 us-gaap Profit Loss
ProfitLoss
681001 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-833200 usd
us-gaap Profit Loss
ProfitLoss
-284987 usd
us-gaap Profit Loss
ProfitLoss
-1701434 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.87
CY2023Q2 igi Weightedaveragecommonsharesoutstanding
Weightedaveragecommonsharesoutstanding
494960 shares
CY2022Q2 igi Weightedaveragecommonsharesoutstanding
Weightedaveragecommonsharesoutstanding
443953 shares
igi Weightedaveragecommonsharesoutstanding
Weightedaveragecommonsharesoutstanding
483243 shares
igi Weightedaveragecommonsharesoutstanding
Weightedaveragecommonsharesoutstanding
440004 shares
CY2023Q2 igi Weightedaveragecommonsharesoutstanding Diluted
WeightedaveragecommonsharesoutstandingDiluted
638776 shares
CY2022Q2 igi Weightedaveragecommonsharesoutstanding Diluted
WeightedaveragecommonsharesoutstandingDiluted
443953 shares
igi Weightedaveragecommonsharesoutstanding Diluted
WeightedaveragecommonsharesoutstandingDiluted
483243 shares
igi Weightedaveragecommonsharesoutstanding Diluted
WeightedaveragecommonsharesoutstandingDiluted
440004 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
325634 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
319350 shares
CY2023Q2 igi Aggregate Shares Of Common Stock Authorized Under Stock Option Plans And Agreements
AggregateSharesOfCommonStockAuthorizedUnderStockOptionPlansAndAgreements
249113 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
47600 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1267 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.10 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
26159 usd
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
51708 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52631 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
32600 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
15000 shares
CY2023Q2 igi Option Price
OptionPrice
1.17
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
131789 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
47600 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.20
igi Number Of Options Expired
NumberOfOptionsExpired
-6335 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.85
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
173054 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M24D
igi Aggregate Intrinsic Value Outstanding
AggregateIntrinsicValueOutstanding
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
158054 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y8M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
158054 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M12D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
igi Leases Expires
LeasesExpires
May 31, 2029
igi Rent Expense
RentExpense
118487 usd
igi Leases Rate
LeasesRate
0.02 pure
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
691009 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
691009 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604366 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
645095 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
80762 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
76826 usd
CY2023Q2 igi Operating Lease Liability Long Term
OperatingLeaseLiabilityLongTerm
531374 usd
CY2022Q4 igi Operating Lease Liability Long Term
OperatingLeaseLiabilityLongTerm
572560 usd
CY2023Q2 igi Operating Lease Liability1
OperatingLeaseLiability1
612136 usd
CY2022Q4 igi Operating Lease Liability1
OperatingLeaseLiability1
649386 usd
CY2023Q2 igi Discount Rate Operating Leas
DiscountRateOperatingLeas
0.07 pure
CY2022Q4 igi Discount Rate Operating Leas
DiscountRateOperatingLeas
0.07 pure
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
345000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
299000 usd

Files In Submission

Name View Source Status
0001654954-23-012978-index-headers.html Edgar Link pending
0001654954-23-012978-index.html Edgar Link pending
0001654954-23-012978.txt Edgar Link pending
0001654954-23-012978-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
igi-20230630.xsd Edgar Link pending
igi_10q.htm Edgar Link pending
igi_ex101.htm Edgar Link pending
igi_ex101img3.jpg Edgar Link pending
igi_ex102.htm Edgar Link pending
igi_ex102img1.jpg Edgar Link pending
igi_ex102img10.jpg Edgar Link pending
igi_ex102img11.jpg Edgar Link pending
igi_ex102img12.jpg Edgar Link pending
igi_ex102img13.jpg Edgar Link pending
igi_ex102img14.jpg Edgar Link pending
igi_ex102img15.jpg Edgar Link pending
igi_ex102img16.jpg Edgar Link pending
igi_ex102img17.jpg Edgar Link pending
igi_ex102img18.jpg Edgar Link pending
igi_ex102img19.jpg Edgar Link pending
igi_ex102img2.jpg Edgar Link pending
igi_ex102img20.jpg Edgar Link pending
igi_ex102img21.jpg Edgar Link pending
igi_ex102img22.jpg Edgar Link pending
igi_ex102img23.jpg Edgar Link pending
igi_ex102img24.jpg Edgar Link pending
igi_ex102img25.jpg Edgar Link pending
igi_ex102img26.jpg Edgar Link pending
igi_ex102img3.jpg Edgar Link pending
igi_ex102img4.jpg Edgar Link pending
igi_ex102img5.jpg Edgar Link pending
igi_ex102img6.jpg Edgar Link pending
igi-20230630_cal.xml Edgar Link unprocessable
igi-20230630_def.xml Edgar Link unprocessable
igi-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
igi-20230630_pre.xml Edgar Link unprocessable
igi_10q_htm.xml Edgar Link completed
igi_ex102img7.jpg Edgar Link pending
igi_ex102img8.jpg Edgar Link pending
igi_ex102img9.jpg Edgar Link pending
igi_ex103.htm Edgar Link pending
igi_ex103img1.jpg Edgar Link pending
igi_ex103img2.jpg Edgar Link pending
igi_ex103img3.jpg Edgar Link pending
igi_ex103img4.jpg Edgar Link pending
igi_ex103img5.jpg Edgar Link pending
igi_ex103img6.jpg Edgar Link pending
igi_ex103img7.jpg Edgar Link pending
igi_ex103img8.jpg Edgar Link pending
igi_ex103img9.jpg Edgar Link pending
igi_ex311.htm Edgar Link pending
igi_ex312.htm Edgar Link pending
igi_ex321.htm Edgar Link pending
igi_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending